Review
Open access
Sep 2026
Cardiovascular protection beyond glucose lowering: GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonism in contemporary cardiology
This Review provides a practical phenotype-directed treatment algorithm incorporating atherosclerotic cardiovascular disease, obesity, type 2 diabetes, chronic kidney disease, HFpEF, sodium–glucose cotransporter 2 inhibitor use and patient-specific treatment constraints.
Ming-Zhen Li
· Frontiers in Cardiovascular... · 0 citations